Not applicableStudy completedNCT00676169What this trial is testingThe EPIC Observational StudyWho this might be right forCystic Fibrosis CF Therapeutics Development Network Coordinating Center 1,248
Testing effectiveness (Phase 2)Study completedNCT00794586What this trial is testingStudy Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung InfectionWho this might be right forCystic Fibrosis Gilead Sciences 120
Post-approval studies (Phase 4)UnknownNCT01667094What this trial is testingA Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic FibrosisWho this might be right forCystic Fibrosis The Alfred 50
Large-scale testing (Phase 3)Study completedNCT02054156What this trial is testingOPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic FibrosisWho this might be right forCystic Fibrosis Bonnie Ramsey 221
Large-scale testing (Phase 3)Ended earlyNCT03409679What this trial is testingPivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas AeruginosaWho this might be right forPneumonia Polyphor Ltd. 41
Not applicableLooking for participantsNCT03044223What this trial is testingMonocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa SepsisWho this might be right forPseudomonas InfectionsPseudomonas SepticemiaPseudomonas; Pneumonia+6 more University of Ulm 100
Large-scale testing (Phase 3)Ended earlyNCT03582007What this trial is testingPivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to PseudomonasWho this might be right forPneumonia Polyphor Ltd. 2
Early research (Phase 1)Ended earlyNCT03309358What this trial is testingThe Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic FibrosisWho this might be right forLung DiseasesPulmonary DiseaseCystic Fibrosis+13 more Synspira, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT04596319What this trial is testingPh 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic FibrosisWho this might be right forCystic FibrosisPseudomonas AeruginosaPseudomonas+2 more Armata Pharmaceuticals, Inc. 29